What Emage Fibroid Centers does

Emage Fibroid Centers, operated by IR MSO LLC, is a U.S. outpatient healthcare services provider specializing in non-surgical treatment of uterine fibroids via uterine fibroid embolization (UFE). UFE is an image-guided, catheter-based procedure in which an interventional radiologist threads a catheter into the uterine artery and injects microscopic particles to cut off blood flow to fibroids, causing them to shrink and die while preserving the uterus. The procedure is performed under local anesthesia and conscious sedation in private outpatient facilities, with same-day discharge and approximately one week of recovery, and requires only a Band-Aid-sized skin nick. The company also offers initial consultations (in-person or via telehealth) and MRI imaging services used to determine UFE candidacy.

The company is led by Dr. John Lipman, MD, FSIR, a globally recognized pioneer in UFE with 30 years of experience and over 10,000 patients treated at the legacy Atlanta Fibroid Center he founded in 2005. The clinical team includes Dr. Philip A. Adler (medical director of the Detroit center), Dr. Sima Banerjee, and Dr. Keith Horton, all board-certified interventional radiologists. Emage operates an outpatient network spanning Southfield, Michigan (Detroit metro); Smyrna and Lawrenceville, Georgia (Atlanta metro, via the Atlanta Fibroid Center partnership); and announced locations in Washington D.C. and Richmond, Virginia. The Free From Fibroids Foundation, a 501c3 founded by Dr. Lipman in 2021, operates as a separate awareness and education entity.

Emage generates revenue on a professional services / pay-as-you-go basis, billing insurers and patients per procedure and consultation. UFE is covered by most major commercial insurance carriers plus Medicare and Medicaid, and detailed cost estimates are provided during the initial consultation. Go-to-market combines direct-to-patient scheduling (phone and website), telehealth consultations, physician/OB-GYN referral networks, influencer partnerships (e.g., @Randirossario in Metro Detroit), and community/health-equity partnerships with nonprofits such as DABO Detroit and the White Dress Project. Target customers are women with symptomatic fibroids — including those seeking to preserve fertility and African American women, who are disproportionately affected — primarily in the Detroit and Atlanta metros with planned expansion into the D.C. and Richmond markets.

Name

Emage Fibroid Centers

Legal name

IR MSO LLC

Website

https://emagefibroidcenters.com

Company type

Private

Operating status

Operating

Short description

Emage Fibroid Centers operates a U.S. outpatient network providing non-surgical uterine fibroid embolization (UFE) and related consultations and MRI imaging. It serves women with symptomatic fibroids in Detroit, Atlanta, and planned Washington D.C. and Richmond markets, billing through insurance including Medicare and Medicaid.

Ownership category

akta.pro rank

Product category

Outpatient Uterine Fibroid Treatment

NAICS

Outpatient Care Centers (6214), Freestanding Ambulatory Surgical and Emergency Centers (621493), Diagnostic Imaging Centers (621512)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Interventional Radiology & Image-Guided Therapy Systems (HLAHABAG)

Keywords

• Uterine fibroid treatment
• Minimally invasive radiology
• Outpatient fibroid care
• Women's health services
• Interventional radiology clinics

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Healthcare Services Revenue: Emage Fibroid Centers generates revenue through billable medical procedures and consultations. Services include UFE treatment, MRI imaging, and follow-up care. Revenue is primarily derived from insurance reimbursements and patient payments. Most major insurance carriers including Medicare and Medicaid are accepted.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Emage Fibroid Centers operates a network of outpatient centers providing non-surgical uterine fibroid embolization (UFE), a minimally invasive, image-guided procedure that blocks blood supply to fibroids via a catheter through a single Band-Aid-sized skin nick. Services span a five-step patient journey of consultation (in-person or telehealth), MRI imaging, candidacy review, the UFE procedure, and follow-up care, all delivered by board-certified interventional radiologists with same-day discharge and approximately one-week recovery. Most major insurance carriers including Medicare and Medicaid are accepted.

Product overview

Emage Fibroid Centers operates a network of outpatient healthcare centers offering Uterine Fibroid Embolization (UFE) as the core treatment for uterine fibroids. The unified service offering encompasses consultation (in-person or via telehealth), diagnostic MRI imaging, the UFE procedure, and follow-up care. Atlanta Fibroid Center serves as a partner location in the Atlanta metropolitan area. All services are delivered by board-certified interventional radiologists in private, fully equipped outpatient facilities.

Differentiator

Problem solved

Functional benefit

Products and services

• Uterine Fibroid Embolization (UFE) Non-surgical, image-guided outpatient procedure that treats uterine fibroids by blocking their blood supply through a catheter inserted via a single Band-Aid-sized skin nick. Performed by board-certified interventional radiologists in a private clinical setting under local anesthesia and conscious sedation, with same-day discharge and approximately one-week recovery. Indicated for women with symptomatic fibroids seeking to preserve the uterus and avoid hysterectomy or other invasive surgery.
• UFE Consultation Services
• MRI Imaging
• Atlanta Fibroid Center Partner outpatient fibroid treatment center in the Atlanta metropolitan area with two locations (Smyrna and Lawrenceville, GA) offering UFE procedures performed by Dr. John Lipman and Dr. Sima Banerjee. One of the nation's leading centers dedicated exclusively to non-surgical fibroid treatment, serving patients from across the U.S. and around the world.

Quantifiable outcome

• UFE procedures successfully performed with same-day discharge and approximately one week recovery time
• +3 more outcomes

Named customers9 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Six partnerships are on record, tiered core and minor.

• White Dress ProjectcoreStrategic or Co-development Partner · 1 June 2026Emage Fibroid Centers is a sponsor of the White Dress Project's 2026 Empowerment Experience (July 24-26), which will feature a session on UFE led by Dr. John Lipman. The partnership aims to raise awareness about uterine fibroids and non-surgical treatment options during Fibroid Awareness Month.
• DABO DetroitcoreStrategic or Co-development Partner · 1 June 2026Emage has joined forces with DABO Detroit, a nonprofit community organization, to help ensure women are aware of fibroid symptoms and treatment options. The partnership focuses on community education and outreach in the Metro Detroit area.
• Randirossario (Social Media Influencer)minorGTM or Marketing Partner · 1 June 2026Social media influencer partnership with @Randirossario based in Metro Detroit where Emage's Southfield location serves as one of the only outpatient centers specializing in UFE in the area.
• Foundation for Women's Health (FWH)coreStrategic or Co-development Partner · 1 May 2026Dr. John Lipman, founder of Emage Fibroid Centers, donated $100,000 to the FWH x Lupita Nyong'o Uterine Fibroid Research Grant. The partnership supports clinical research for non-invasive fibroid treatments and raises awareness about non-surgical options.
• Atlanta Fibroid CentercoreStrategic or Co-development Partner · 1 May 2026Atlanta Fibroid Center, founded by Dr. John Lipman in 2005, is a partner center of Emage Fibroid Centers. It is one of the nation's leading centers dedicated exclusively to non-surgical fibroid treatment, serving patients from across the US and around the world.
• Free From Fibroids FoundationcoreStrategic or Co-development Partner · 1 January 2021Free From Fibroids Foundation is a 501c3 organization founded by Dr. Lipman, dedicated to eradicating healthcare disparities in fibroid treatment. The foundation works to expand awareness of non-surgical options and empower women with information to make confident health decisions.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Atlanta Fibroid Center: Founder-affiliated partner center operating two Atlanta locations providing the same UFE procedure to the same patient demographic. Direct service overlap and shared physician team make it Emage's most direct peer.
• USA Fibroid Centers: National network of outpatient centers dedicated exclusively to UFE, serving the same patient population with the same procedure. Closest scaled multi-site competitor and direct comparator on clinic model.
• VIVA EVE: Specialty fibroid treatment center in the New York metro offering UFE and other non-surgical fibroid treatments. Direct competitor targeting the same fibroid patient demographic with a similar outpatient model.
• Fibroid Institute of Texas: Outpatient fibroid treatment center offering UFE and related non-surgical procedures. Direct peer with similar service line, physician-led delivery, and patient education focus.

Broad incumbents

• Mayo Clinic: Major academic health system that performs UFE among many other treatments. Established brand and physician referral base compete for the same fibroid patients, but with a much broader portfolio.
• Cleveland Clinic: Large academic medical center offering interventional radiology including UFE. Competes for fibroid patients through integrated OB-GYN and radiology referrals but as part of a full-service hospital system.

Others

• The White Dress Project: Nonprofit fibroid awareness organization that Emage partners with for community education. Comparable ecosystem player driving the same patient-awareness agenda, though not a direct service competitor.
• Foundation for Women's Health: Research-focused foundation that received Emage's $100K fibroid research grant. Indirect peer as a research and awareness stakeholder in the same women's health ecosystem.
• Hologic: Women's health medical device company whose embolization products are commonly used in UFE procedures. Indirect ecosystem participant as an enabling supplier to Emage's clinical workflow.

Emerging players

• Pelvic Rehabilitation Medicine: Specialty pelvic pain and women's health practice expanding UFE-adjacent services. Adjacent emerging player in the same outpatient women's health interventional space.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Emage Fibroid Centers